BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19948263)

  • 1. In vivo protection against Tityus serrulatus scorpion venom by antibodies raised against a discontinuous synthetic epitope.
    Duarte CG; Alvarenga LM; Dias-Lopes C; Machado-de-Avila RA; Nguyen C; Molina F; Granier C; Chávez-Olórtegui C
    Vaccine; 2010 Feb; 28(5):1168-76. PubMed ID: 19948263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of protective antibodies raised in mice by Tityus serrulatus scorpion venom toxins conjugated to bovine serum albumin.
    Machado de Avila RA; Alvarenga LM; Tavares CA; Molina F; Granier C; Chávez-Olórtegui C
    Toxicon; 2004 Sep; 44(3):233-41. PubMed ID: 15302529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope mapping of the antigenic protein TsNTxP from Tityus serrulatus scorpion venom using mouse, rabbit and sheep antibodies.
    Mendes TM; Maria WS; Granier C; Chávez-Olórtegui C; Kalapothakis E
    Toxicon; 2004 Nov; 44(6):617-24. PubMed ID: 15501287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for the cross-reactivity of antibodies elicited by a natural anatoxin with alpha- and beta-toxins from the venom of Tityus serrulatus scorpion.
    Chavez-Olortegui C; Molina F; Granier C
    Mol Immunol; 2002 Mar; 38(11):867-76. PubMed ID: 11922945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of neutralizing antibodies against Tityus serrulatus scorpion toxins by immunization with a mixture of defined synthetic epitopes.
    Alvarenga LM; Diniz CR; Granier C; Chávez-Olórtegui C
    Toxicon; 2002 Jan; 40(1):89-95. PubMed ID: 11602284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of a neutralizing murine monoclonal antibody against Tityus serrulatus scorpion venom.
    Alvarenga LM; Machado de Avila RA; Amim PR; Martins MS; Kalapothakis E; de Lima ME; Santos RG; Granier C; Chávez-Olórtegui C
    Toxicon; 2005 Nov; 46(6):664-71. PubMed ID: 16168449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of antibody-reactive peptides from discontinuous parts of scorpion toxins.
    Alvarenga L; Moreau V; Felicori L; Nguyen C; Duarte C; Chavez-Olortegui C; Molina F; Martin-Eauclaire MF; Granier C
    Vaccine; 2010 Jan; 28(4):970-80. PubMed ID: 19962461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological characterization of a non-toxic peptide conferring protection against the toxic fraction (AahG50) of the Androctonus australis hector venom.
    Srairi-Abid N; Kaabi H; Mlayah-Bellalouna S; Mejri T; Sampieri F; El Ayeb M
    Toxicon; 2008 Mar; 51(3):353-62. PubMed ID: 18054371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of epitopes in the toxins of Tityus serrulatus scorpions and neutralizing potential of therapeutic antivenoms.
    Maria WS; Velarde DT; Alvarenga LM; Nguyen C; Villard S; Granier C; Chávez-Olórtegui C
    Toxicon; 2005 Aug; 46(2):210-7. PubMed ID: 15970301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo protection against Tityus serrulatus scorpion toxins by immunization of mice with a non-toxic protein.
    Moreira-Ferreira AM; Kalapothakis E; Diniz CR; Chávez-Olórtegui C
    Toxicon; 1998 Feb; 36(2):333-9. PubMed ID: 9620580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective Tityus serrulatus anti-venom produced using the Ts1 component.
    Mendes TM; Dias F; Horta CC; Pena IF; Arantes EC; Kalapothakis E
    Toxicon; 2008 Dec; 52(7):787-93. PubMed ID: 18775739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing capacity of antibodies elicited by a non-toxic protein purified from the venom of the scorpion Tityus serrulatus.
    Chávez-Olórtegui C; Kalapothakis E; Ferreira AM; Ferreira AP; Diniz CR
    Toxicon; 1997 Feb; 35(2):213-21. PubMed ID: 9080578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Tityus scorpion venoms using synaptosome binding assays and reactivity towards Venezuelan and Brazilian antivenoms.
    Borges A; De Sousa L; Espinoza J; Melo MM; Santos RG; Kalapothakis E; Valadares D; Chávez-Olórtegui C
    Toxicon; 2008 Jan; 51(1):66-79. PubMed ID: 17920649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General characterization of Tityus fasciolatus scorpion venom. Molecular identification of toxins and localization of linear B-cell epitopes.
    Mendes TM; Guimarães-Okamoto PT; Machado-de-Avila RA; Oliveira D; Melo MM; Lobato ZI; Kalapothakis E; Chávez-Olórtegui C
    Toxicon; 2015 Jun; 99():109-17. PubMed ID: 25817000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of neutralizing antibodies against Tityus serrulatus toxins by immunization with a recombinant nontoxic protein.
    Guatimosim SC; Kalapothakis E; Diniz CR; Chávez-Olórtegui C
    Toxicon; 2000 Jan; 38(1):113-21. PubMed ID: 10669016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of a human antibody fragment specific for Ts1 toxin from Tityus serrulatus scorpion.
    Amaro I; Riaño-Umbarila L; Becerril B; Possani LD
    Immunol Lett; 2011 Sep; 139(1-2):73-9. PubMed ID: 21620895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning and genomic analysis of TsNTxp: an immunogenic protein from Tityus serrulatus scorpion venom.
    Guatimosim SC; Prado VF; Diniz CR; Chávez-Olórtegui C; Kalapothakis E
    Toxicon; 1999 Mar; 37(3):507-17. PubMed ID: 10080354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General biochemical and immunological characterization of the venom from the scorpion Tityus trivittatus of Argentina.
    de Roodt AR; Coronas FI; Lago N; González ME; Laskowicz RD; Beltramino JC; Saavedra S; López RA; Reati GJ; Vucharchuk MG; Bazán E; Varni L; Salomón OD; Possani LD
    Toxicon; 2010; 55(2-3):307-19. PubMed ID: 19706301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice.
    Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV
    Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against Tityus discrepans venom do not abolish the effect of Tityus serrulatus venom on the rat sodium and potassium channels.
    Borges A; Tsushima RG; Backx PH
    Toxicon; 1999 Jun; 37(6):867-81. PubMed ID: 10340827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.